A model N-ethyl-1,10-dioxo-3-phenylpyrano[3,2-f ]quinoline-9-carboxylic acid (8) and the isomeric (2-substituted) pyrano[2,3-f ]quinoline-9-carboxylic acids (6 and 7) were prepared from the corresponding 6/7-aminochromen-4-ones via the Gould-Jacobs reaction. The new tricyclic heterocycles 6-8 exhibit moderate antibacterial activity (MIC = 16 -64 µg mL −1 ) against E. coli and S. aureus.
Introduction
Chromones are naturally occurring compounds with a 4-benzopyrone moiety [1, 2] . The compounds of this family are well-known as antioxidants [3, 4] . Some chromone derivatives, such as khellin [5] and 2,4-thiazolidenedione [6 -8] , have antispasmodic and antidiabetic activities, respectively. These biological properties made this family of compounds the target of innumerous studies focusing on syntheses and structural modifications [9 -15] . Flavones, e. g. 1-3, are 2-phenyl-substituted chromones [16, 17] which exhibit biocidal [18 -20] , antitumor [21] , anti-inflammatory [22, 23] , antiviral [24, 25] , anti-HIV [26] , and other activities.
Synthetic 4-oxoquinoline-3-carboxylic acids, exemplified by norfloxacin (4a) [27, 28] and ciprofloxacin (4b) [29 -32] (Fig. 1) , constitute a major class of therapeutic agents which have a broad spectrum of antibacterial activity. For most current SAR studies, a hydrogen atom at position 2, a free carboxyl group at position 3, and a keto group at position 4 cannot be changed without significant loss of activity. sition (e. g., an ethyl or cyclopropyl group) is also essential for attainment of high potency [33 -36] . Fused heterocyclic rings with a bridge between the 5-and 6-positions have not been extensively investigated in this system. Accordingly, we have envisaged to prepare new tricyclic heterocycles (6-8, Fig. 2) , whereby a 4-pyranone ring is [ f ]-fused onto the 1-ethyl-4-oxoquinoline-3-carboxylic acid moiety. Such hybrid molecules combine the structural features of flavone (rings A, B) and 4-quinolone (rings B, C) entities and might display interesting biological properties. In this context it is worth noting that a linear 4H-pyrano[g]-fused quinoline 5 has recently been reported [37] . This single example is a 7-carboxylic ester that also lacks a suitable alkyl substituent at N(9)-locus and is thus expected to exhibit low anti-bacterial activity.
Results and Discussion

Syntheses
The synthetic strategy towards the target tricyclic compounds 6 and 7 commenced with the 7-aminochromen-4-one, expected to be annelating the 4-pyridone moiety as outlined in Scheme 1. Thus, treatment of 9 and 10 with diethyl ethoxymethylenemalonate gave the respective enamine derivatives 11 and 12. The latter intermediates underwent thermal intramolecular cyclization, regioselectively at C-8, to deliver the corresponding pyrano[2,3-f ]quinoline-9-carboxylic esters 13 and 14 under Gould-Jacobs reaction conditions [38] . Subsequent N(1)-ethylation of 13 and 14 afforded the respective derivatives 15 and 16, and their acid-catalyzed hydrolysis furnished the respective targeted 9-carboxylic acids 6 and 7. Likewise, 6-aminoflavone 17 was converted into the respective N-ethylpyrano [3,2- f ]quinoline-9-carboxylic acid 8 via the consecutive intermediates 18, 19 and 20 as depicted in Scheme 2. The newly synthesized compounds 6-20 were characterized by NMR and MS spectral data (see Experimental Section) which are consistent with the suggested structures. Thus, the mass spectra display the correct molecular ion peaks for which the measured high resolution (HRMS) data are in good agreement with the calculated values. DEPT and 2D (COSY, HMQC, HMBC) experiments showed correlations that helped in the 1 H and 13 C signal assignments to the different carbons and their attached and/or neighboring hydrogens.
Antibacterial activity
Compounds 6-8 were tested in vitro in aqueous DMSO solutions against Gram-negative Escherichia coli ATCC 8739 and Gram-positive Staphylococcus aureus ATCC 6538 bacterial species using ciprofloxacin as reference. The antibacterial activity was evaluated by the minimal inhibitory concentration (MIC) technique. Compounds 6-8 exhibit a moderate level of antibacterial activity (MIC = 16 -64 µg mL −1 ) against E. coli and S. aureus.
Experimental Section
The following chemicals, used in this study, were purchased from Acros and used as received: Diethyl ethoxymethylenemalonate, diphenyl ether and iodoethane. 7-Aminoflavone, 6-aminoflavone and 7-amino-2-methyl-4H-chromen-4-one were purchased from Aldrich. Melting points were determined on a Gallenkamp electrothermal melting apparatus in open capillary tubes. 1 H and 13 C NMR spectra were recorded on a 500 MHz spectrometer (Bruker Avance-III). Chemical shifts are expressed in ppm (δ units), with TMS as internal standard; J values for 1 H-1 H coupling constants are given in Hertz. High-resolution mass spectra (HRMS) were acquired (in positive or negative ion mode) using electrospray ion trap (ESI) technique by collisioninduced dissociation on a Bruker APEX-4 (7-Tesla) instrument. The samples were dissolved in acetonitrile, diluted in spray solution (methanol-water 1 : 1 v/v + 0.1 % formic acid) and infused using a syringe pump with a flow rate of 2 µL min −1 . External calibration was conducted using arginine cluster in a mass range m/z = 175 -871. Elemental analyses were performed on a Euro Vector elemental analyzer, model EA 3000.
Antibacterial tests
The MICs were determined by the conventional agar dilution procedures according to the method of Mueller-Hinton. (R = Et) Stock solutions (1000 µg mL −1 ) of the test compounds were prepared with DMSO. Serial dilutions were then made to obtain test concentrations in the range 128 -0.5 µg mL −1 . The agar plates were inoculated with approximately 105 CFU per spot. The agar plates were then incubated at 37 • C for 18 h. The MICs were taken as the lowest concentration of the test compounds that inhibits visible growth.
Diethyl 2-[(4-oxochromenylamino)methylene]malonates
11, 12 and 18; general procedure A mixture of the particular aminochromen-4-one (4.2 mmol) and diethyl ethoxymethylenemalonate (5.0 mmol) was heated at 130 -140 • C for 2 h, during which time the resulting ethanol was distilled off. Thereafter, the reaction mixture was cooled to 60 • C and poured onto 50 mL of n-hexane. The resulting solid precipitate was collected by suction filtration, dried and recrystallized from ethyl acetate to give the respective 2-[(4-oxochromenylamino)methylene]malonate.
Diethyl 2-[(4-oxo-2-phenyl-4H-chromen-7-ylamino)-methylene]malonate (11)
Yield: 94 %; m. p. 185 -187 • C. 
Diethyl 2-[(2-methyl-4-oxo-1H-chromen-7-ylamino)-methylene]malonate (12)
Yield
Diethyl 2-[(4-oxo-2-phenyl-1H-chromen-6-ylamino)-methylene]malonate (18)
Ethyl pyranoquinoline-9-carboxylates 13, 14 and 19; general procedure
The particular diethyl 2-[4-(oxochromenylamino)methylene]malonate (11, 12, 18) (2.45 mmol) was added to diphenyl ether (10 mL) and heated at 245 -250 • C for 1 h. The product solution was allowed to cool to 60 • C, and then the warm solution was poured onto 50 mL of n-hexane. The precipitate was collected by suction filtration, washed with hot ethyl acetate, and dried to give the corresponding pyranoquinolone in fairly pure state.
Ethyl 4,10-dioxo-2-phenyl-7,10-dihydro-4H-pyrano-[2,3-f]quinoline-9-carboxylate (13)
Yield: 85 %; m. p. 292 -293 • C. 
Ethyl 2-methyl-4,10-dioxo-7,10-dihydro-4H-pyrano-[2,3-f]quinoline-9-carboxylate (14)
Yield: 90 %; m. p. 308 -309 • C. 
Ethyl 7-ethylpyrano[2,3-f]quinoline-9-carboxylates 15, 16 and 20; general procedure
A stirred mixture of compound 5 (1.38 mmol), K 2 CO 3 (6.92 mmol), iodoethane (6.92 mmol), and absolute ethanol (10 mL) was refluxed for 10 h. The reaction mixture was cooled to r. t. and diluted with 50 mL of water. The precipitated solid product was collected by suction filtration, washed with water, dried and recrystallized from the appropriate solvent. [2,3- 
Ethyl 7-ethyl-4,10-dioxo-2-phenyl-7,10-dihydro-4H-pyrano
7-Ethylpyranoquinoline-9-carboxylic acids 6-8; general procedure
A suspension of the appropriate ethyl ester (0.51 mmol) in 20 mL of 6 N aq. HCl was refluxed (oil bath, 110 • C) for 48 h. Thereafter, the reaction mixture was cooled and poured onto ice water (30 mL); the precipitated product was collected by suction filtration, washed with water (3 × 4 mL), redissolved in 20 mL of 1 N aq. K 2 CO 3 and filtered. The aqueous filtrate was neutralized with 6 N aq. HCl. The resulting solid was collected by suction filtration, dried and recrystallized from the appropriate solvent.
